Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray

Mostrar otras versiones (1)

The current practice for diagnosis of COVID-19, based on SARS-CoV-2 PCR testing of pharyngeal or respiratory specimens in a symptomatic patient at high epidemiologic risk, likely underestimates the true prevalence of infection. Serologic methods can more accurately estimate the disease burden by det...

Descripción completa

Detalles Bibliográficos
Autores principales: de Assis, Rafael R., Jain, Aarti, Nakajima, Rie, Jasinskas, Algis, Felgner, Jiin, Obiero, Joshua M., Norris, Philip J., Stone, Mars, Simmons, Graham, Bagri, Anil, Irsch, Johannes, Schreiber, Martin, Buser, Andreas, Holbro, Andreas, Battegay, Manuel, Hosimer, Philip, Noesen, Charles, Adenaiye, Oluwasanmi, Tai, Sheldon, Hong, Filbert, Milton, Donald K., Davies, D. Huw, Contestable, Paul, Corash, Laurence M., Busch, Michael P., Felgner, Philip L., Khan, Saahir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782488/
https://www.ncbi.nlm.nih.gov/pubmed/33397903
http://dx.doi.org/10.1038/s41467-020-20095-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782488/
https://www.ncbi.nlm.nih.gov/pubmed/33397903
http://dx.doi.org/10.1038/s41467-020-20095-2

Ejemplares similares